Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 134Lung Neoplasms 50Adenocarcinoma of Lung 18Adenocarcinoma, Bronchiolo-Alveolar 10Brain Neoplasms 9NSCLC 8Neoplasms 5Neoplasm Metastasis 5Adenocarcinoma 4Respiratory Tract Diseases 3Carcinoma 3Thoracic Neoplasms 2Mesothelioma, Malignant 2Head and Neck Neoplasms 2Tongue Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Stage IV EGFR Mutated Non-Small Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumor, Pleural 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Respiratory Tract Neoplasms 1Recurrence 1Previous Treated Metastatic Non-small Cell Lung Cancer 1Pleural Effusion, Malignant 1Parathyroid Neoplasms 1Non-squamous Non-small Cell Lung Cancer 1Non-small Cell Lung Cancer Metastatic 1

Interventions

Carboplatin 9Pemetrexed 6Erlotinib Hydrochloride 5pembrolizumab 3osimertinib 3durvalumab 3camrelizumab 3Gemcitabine 3Gefitinib 3Cisplatin 3selpercatinib 2pralsetinib 2apatinib 2Radiosurgery 2taletrectinib 1sotorasib 1sintilimab 1repotrectinib 1patritumab 1necitumumab 1ficlatuzumab 1exemestane 1entinostat 1cobimetinib 1ceralasertib 1alectinib 1Vinorelbine 1Tyrosine Kinase Inhibitors 1Telescopes 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Respiratory Tract Diseases × Gefitinib × Thoracic × Clear all
NCT03653546 2025-09-10

BM

Alpha Biopharma (Jiangsu) Co., Ltd.

Phase 2/3 Completed
492 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases

NCT01024413 2017-03-01

Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations

Chinese Society of Lung Cancer

Phase 3 Completed
256 enrolled
Thoracic

Lung Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT01039948 2015-04-08

A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer

AVEO Pharmaceuticals, Inc.

Phase 1/2 Completed
203 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡